Skip to content

Screening for Risk Factors of Prediabetes Among Adult Patients at Sohag University Hospital

Screening for Risk Factors of Prediabetes Among Adults Patients at Sohag University Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05864183
Enrollment
200
Registered
2023-05-18
Start date
2023-04-15
Completion date
2023-12-31
Last updated
2023-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PreDiabetes

Brief summary

* Prediabetes is an intermediate state of hyperglycemia with glycemic parameters above normal but below the diabetes threshold.. * during the average 3 years of follow-up Prediabetes is diagnosed based on laboratory tests: fasting plasma glucose level (100-125 mg/dl) ;HbA1c, (5.7-6.4%) or plasma glucose level after an oral glucose tolerance test ( 140-199 mg/dl). * Reports estimate that more than 470 million people will have prediabetes by 2030. * According to an expert panel of the American Diabetes Association, up to 70% of individuals with prediabetes will eventually develop diabetes. * Observational evidence suggests as association between prediabetes and complications of diabetes such early nephropathy(10%) , small fiber neuropathy(18-25 %), early retinopathy (8-12%) and risk of macrovascular disease (52%) . * Screening for prediabetes is designed to save lives or enhance an individual's quality of life by early detection so that screening will minimize the risk of developing diabetes or its complications .

Detailed description

* In this case control study we aim to screen for risk factors of prediabetes among adult patients to minimize the risk of developing diabetes or its complications . * Prediabetes screening is also required to minimize medical costs such as hospitalization, outpatient care, surgery, medications, and laboratory test costs . * Several studies had shown efficacy of lifestyle interventions in diabetes prevention by targeting obesity with increase in physical activity and dietary changes with a relative risk reduction of 40%-70% in adults with prediabetes ,also there is increasing evidence to prove the efficacy of pharmacotherapy in prevention of diabetes in adults with prediabetes

Interventions

DIAGNOSTIC_TESTHbA1c

HbA1c will be measured for all patients to minimize the risk of developing diabetes or its complications .

DIAGNOSTIC_TESTlipid profile

lipid profile will be measured for all patients to minimize the risk of developing diabetes or its complications .

DIAGNOSTIC_TESTCBC

CBC will be measured for all patients to minimize the risk of developing diabetes or its complications

DIAGNOSTIC_TESTAlb/cr ratio

Alb/cr will be measured for all patients to minimize the risk of developing diabetes or its complications

DIAGNOSTIC_TESTserum creatinine .

serum creatinine will be measured for all patients to minimize the risk of developing diabetes or its complications

DIAGNOSTIC_TESTCRP

CRP will be measured for all patients to minimize the risk of developing diabetes or its complications

DIAGNOSTIC_TESTurine analysis

urine analysis will be measured for all patients to minimize the risk of developing diabetes or its complications

DIAGNOSTIC_TESTECG

ECG will be done for all patients to minimize the risk of developing diabetes or its complications

DIAGNOSTIC_TESTfundus examination

fundus examination will be done for all patients to minimize the risk of developing diabetes or its complications

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult patient above 18 years old .

Exclusion criteria

* all patients known to be diabetics . * pregnancy . * chronic depleting diseases, * Those who were taking drugs known to influence blood glucose levels e.g. metformin, thiazolidinedione and steroids.

Design outcomes

Primary

MeasureTime frameDescription
comparison between the measurement of HbA1c in normal non prediabetics and prediabetics at Sohag university hospital .6 monthsanalysis of HbA1c measurements and compare the results in both groups

Countries

Egypt

Contacts

Primary ContactNermeen F Ezzat, resident
nerminfathy@med.sohag.edu.eg01273878007
Backup ContactAdel A El sayed, professor
01006677651

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026